The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
A newly published study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits ...
Arginine reduced Alzheimer's plaques and improved memory in mice, offering hope for future medical treatments.
Adam Howitt was diagnosed with Alzheimer’s at age 50. However, he has seen the progression of the disease slow thanks to ...
Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.
Jacobin on MSNOpinion
The profit motive behind new Alzheimer’s treatments
Big Pharma and industry-funded advocacy groups are promoting Alzheimer’s blood testing that could label millions of Americans ...
Early diagnoses of Alzheimer’s disease could let patients decide whether to try treatments that have helped in past clinical ...
Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...
Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, ...
In a study published in Neurochemistry International, researchers found that arginine reduced the buildup of toxic amyloid β ...
A variety of Alzheimer’s medications can help manage different symptoms and improve quality of life as the disease progresses. Alzheimer’s medications help manage symptoms by improving memory, ...
As researchers investigate three distinct alzheimer’s patterns the potential is clear for more effective Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results